| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Cynata Therapeutics Limited (AU: CYP)
CYP Technical Analysis
5
| As on 11th Jul 2023 CYP STOCK Price closed @ 0.12 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.38 & Strong Sell for SHORT-TERM with Stoploss of 0.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CYPSTOCK Price
| Open | 0.14 | Change | Price | % |
| High | 0.14 | 1 Day | -0.02 | -14.29 |
| Low | 0.12 | 1 Week | 0.00 | 0.00 |
| Close | 0.12 | 1 Month | -0.02 | -14.29 |
| Volume | 176251 | 1 Year | -0.37 | -75.51 |
| 52 Week High 0.54 | 52 Week Low 0.11 | ||||
AU Australia Most Active Stocks
| MOB | 0.02 | 100.00% |
| SI6 | 0.01 | % |
| GMN | 0.01 | 0.00% |
| LPD | 0.01 | 0.00% |
| LDX | 0.06 | -14.29% |
| S32 | 3.69 | 3.65% |
| WWI | 0.02 | 100.00% |
| HWK | 0.09 | % |
| SYA | 0.19 | 5.56% |
| G88 | 0.05 | -16.67% |
AU Australia Top Gainers Stocks
AU Australia Top Losers Stocks
| CYP Daily Charts |
CYP Intraday Charts |
Whats New @ Bazaartrend |
CYP Free Analysis |
|
|
CYP Important Levels Intraday
| RESISTANCE | 0.16 |
| RESISTANCE | 0.15 |
| RESISTANCE | 0.14 |
| RESISTANCE | 0.13 |
| SUPPORT | 0.11 |
| SUPPORT | 0.10 |
| SUPPORT | 0.09 |
| SUPPORT | 0.08 |
CYP Forecast May 2024
| 4th UP Forecast | 0.25 |
| 3rd UP Forecast | 0.21 |
| 2nd UP Forecast | 0.18 |
| 1st UP Forecast | 0.16 |
| 1st DOWN Forecast | 0.08 |
| 2nd DOWN Forecast | 0.06 |
| 3rd DOWN Forecast | 0.03 |
| 4th DOWN Forecast | -0.01 |
CYP Weekly Forecast
| 4th UP Forecast | 0.20 |
| 3rd UP Forecast | 0.17 |
| 2nd UP Forecast | 0.16 |
| 1st UP Forecast | 0.14 |
| 1st DOWN Forecast | 0.10 |
| 2nd DOWN Forecast | 0.08 |
| 3rd DOWN Forecast | 0.07 |
| 4th DOWN Forecast | 0.04 |
CYP Forecast2024
| 4th UP Forecast | 0.89 |
| 3rd UP Forecast | 0.64 |
| 2nd UP Forecast | 0.49 |
| 1st UP Forecast | 0.34 |
| 1st DOWN Forecast | -0.1 |
| 2nd DOWN Forecast | -0.25 |
| 3rd DOWN Forecast | -0.4 |
| 4th DOWN Forecast | -0.65 |
Cynata Therapeutics Limited ( AU Australia Symbol : CYP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CYP Business Profile
Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human therapeutic use in Australia. The company's lead therapeutic product candidate is CYP-001, which has completed Phase I clinical trial for the treatment of graft versus host disease. It also develops CYP-004, which is in Phase III clinical trial used for the treatment of osteoarthritis; and products for the treatment of asthma, heart attack, diabetic wounds, coronary artery disease, acute respiratory distress syndrome, brain cancer, melanoma, sepsis, osteoarthritis, and critical limb ischemia, which are in a preclinical model. Cynata Therapeutics Limited has a strategic partnership with Fujifilm to provide clinical and commercial manufacturing services for, and supply of, Cynata's Cymerus therapeutic mesenchymal stem cell products. The company was formerly known as Eco Quest Limited and changed its name to Cynata Therapeutics Limited in October 2013. Cynata Therapeutics Limited was founded in 2011 and is based in Cremorne, Australia. Address: 100 Cubitt Street, Cremorne, VIC, Australia, 3121
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service